Source: Eur Respir J 2013; 41: 664-670
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pelkonen Anna S., Malmström Kristiina, Sarna Seppo, Kajosaari Merja, Klemola Timo, Malmberg L. Pekka, Mäkelä Mika J.. The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J 2013; 41: 664-670

Member's Comments

No comment yet.

Related content which might interest you: The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005 Factors associated with elevated exhaled nitric oxide fraction in infants with recurrent respiratory symptoms Source: Eur Respir J 2013; 41: 189-194 Year: 2013 Low exhaled nitric oxide levels in infants with respiratory symptoms in the first 2 months of life Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Rint, exhaled nitric oxide and the prediction of asthma and respiratory symptoms in children Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005 Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence Source: Eur Respir J 2016; 47: 510-519 Year: 2016 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005 Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 What is in the air of a child with lung disease? Source: Annual Congress 2005 - Paediatric year in review Year: 2005 Infant exhaled nitric oxide does not identify persistent wheezers by the age of four years Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Effects of exacerbations and seasonality on exhaled nitric oxide in COPD Source: Eur Respir J 2005; 26: 1009-1015 Year: 2005 Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Predicting performance of cough reflex sensitivity, exhaled nitric oxide (eNO) and bronchial responsiveness for efficacy of bronchodilator therapy on isolated chronic non-productive cough Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004